LGC is pleased to announce that it will act as global distributor of InBio’s purified food allergen reference materials. This addition expands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification. These unique reagents and assays have applications for food and beverage testing laboratories, food... Read more
Today, LGC announces that Euan O’Sullivan has been appointed Chief Executive Officer (CEO) of the organisation with immediate effect. Euan succeeds Tim Robinson, who will become Chairman of LGC having served as Chief Executive since May 2013. After joining LGC in 2007 as a Non-Executive Director, Euan served as Corporate Development Director from July 2010... Read more
LGC’s SeraCare has expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex™ SARS-CoV-2 Variant Panel 1. The kit contains full SARS-CoV-2 genomic RNA with a focus on S-gene mutations in three prominent variants of concern (UK variant B.1.1.7, South Africa variant B.1.351, and Brazil variant P.1) with vials for each variant as well as... Read more
The UK’s National Measurement Laboratory (NML) at LGC has expanded its portfolio of reference materials to include a new material, LGC7113, which is a fruit squash characterised for sulfur dioxide (SO2) content, traceable to the SI (International System of Units). Sulfur dioxide is a permitted additive used in the production of food and drink which acts as a preservative and antioxidant,... Read more
LGC has expanded its innovative portfolio of SARS-CoV-2 quality solutions with the release of AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid reference material. The product is designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics. It serves as an ideal research tool for assay developers as well as a complete quality solution for clinical laboratories... Read more
LGC is pleased to announce that the ACCURUN® Anti-SARS-CoV-2 Reference Material Kit is now CE marked for in vitro diagnostic use (CE-IVD). With this change in regulatory status, the new product name is ACCURUN Anti-SARS-CoV-2 Controls Kit. Bearing the CE mark and IVD symbol signifies that the ACCURUN Anti-SARS-CoV-2 Controls Kit meets extensive design control requirements. ACCURUN... Read more
LGC’s high-throughput (HTP) RT-PCR testing system for SARS-CoV-2 has been submitted to the FDA for Emergency Use Authorisation (EUA). Testing labs can now leverage LGC’s unrivalled expertise in automated sample preparation and high-throughput RT-PCR workflows in a ready-to-deploy solution. As the need for SARS-CoV-2 testing for both diagnostic and screening applications continues to grow, many organisations are... Read more
(ANN ARBOR, Mich. – February 24, 2020) Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), today announced a partnership agreement with LGC, Biosearch Technologies, a global leader in specialty genomic analysis tools to leverage Swift’s targeted sequencing technology into LGC Biosearch Techologies kits and service... Read more
LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase (RT) designed specifically to meet the needs of diagnostic kit developers. This reverse transcriptase has a temperature optimum from 55 – 80 °C, improving reaction specificity and allowing synthesis from diverse RNA templates. It is also fast, with a reaction time of five... Read more
26 NOV 2018 Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories. SeraCare provides quality control materials for infectious disease testing through their ACCURUN® reagents as well as in the fast growing clinical next-generation sequencing (NGS) market which it addresses through... Read more